General Hospital of Ningxia Medical University
Yinchuan, Ningxia, 750004, China
NCT Number: NCT04272632
The purpose of this study is to investigate the optimal coload guided by inferior vena cava collapsibility index in parturients with prophylactic norepinephrine infusion undergoing cesarean section.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Yinchuan, Ningxia, 750004, China
Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. Vasopressors has been highly recommended for routine prevention and/or treatment of post-spinal anesthesia hypotension. As a potential substitute drug for phenylephrine, norepinephrine has gradually been used in parturients undergoing cesarean section. There's some evidence that prophylactic infusion of norepinephrine could effectively reduce the incidence of post-spinal anesthesia hypotension in parturients undergoing cesarean section. However, our study (NCT03997500) had been shown that inferior vena cava collapsibility index (IVC-CI) markedly decreased in prophylactic norepinephrine infusion versus normal saline after spinal anesthesia and fetal delivery, suggesting that more prudent fluid management is required. The ideal dose of coload and coload is still unknown. Thus, the purpose of this study is to investigate the optimal coload guided by IVC-CI in parturients with prophylactic norepinephrine infusion undergoing cesarean section.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
4 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.
Other names: Crystalloid
8 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.
Other names: Crystalloid
12 ml/kg compound sodium chloride (0.85% NaCl, 0.03% KCl, and 0.033% CaCl2) was given immediately after spinal anesthesia.
Other names: Crystalloid
Time frame: Baseline (before preload)
IVC-CI = [(IVC-max-IVC-min) /IVC-max*100%]
Time frame: Before spinal anesthesia (after preload)
IVC-CI = [(IVC-max-IVC-min) /IVC-max*100%]
Time frame: 5 min after spinal anesthesia
IVC-CI = [(IVC-max-IVC-min) /IVC-max*100%]
Time frame: 5 min after fetal delivery
IVC-CI = [(IVC-max-IVC-min) /IVC-max*100%]
Time frame: Before leaving the operating room
IVC-CI = [(IVC-max-IVC-min) /IVC-max*100%]
Time frame: 1-15 minutes after spinal anesthesia
Systolic blood pressure (SBP) < 80% of the baseline.
Time frame: 1-15 minutes after spinal anesthesia
Systolic blood pressure (SBP) < 60% of the baseline
Time frame: 1-15 minutes after spinal anesthesia
Presence of nausea and vomiting in patients after spinal anesthesia
Time frame: 1-15 minutes after spinal anesthesia
Heart rate < 55 beats/min.
Time frame: 1-15 minutes after spinal anesthesia
Systolic blood pressure (SBP) >120% of the baseline
Time frame: Immediately after delivery
From umbilical vein blood gases
Time frame: Immediately after delivery
From umbilical vein blood gases
Time frame: Immediately after delivery
From umbilical vein blood gases
Time frame: 1min after delivery
A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration
Time frame: 5min after delivery
A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration
Time frame: 1-15 minutes after spinal anesthesia.
Evaluated by performance error (PE).
Time frame: 1-15 minutes after spinal anesthesia.
Evaluated by performance error (PE).
General Hospital of Ningxia Medical University
Other
Coload Optimization Guided by Inferior Vena Cava Collapsibility Index in Parturients With Prophylactic Norepinephrine Infusion Undergoing Cesarean Section: a Randomized, Dose-finding Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06151431
Adverse Effect
Yinchuan, Ningxia, China
View Trial DetailsNCT06158022
Adverse Effect
Yinchuan, Ningxia, China
View Trial DetailsNCT03706755
Adverse Effect, Anesthesia
Tunis, Tunisia
View Trial DetailsNCT06158048
Adverse Effect
Yinchuan, Ningxia, China
View Trial Details